
![]()
Carl Stein, MHS, PA-C
| office address |
45 Castro Street, Suite 402 San Francisco, California 94114-1040 |
| office telephone | +1 (415) 861-2400 |
| citizenship | U.S. |
| languages |
English: native language, fluent Spanish: high level reading, writing, speaking, comprehension |
| education |
University of Michigan Residential College Ann Arbor, Michigan Bachelor of Arts, History, 1982
Physician Assistant Program
at Duke University School of Medicine |
| clinical rotations |
Family Medicine: Inpatient & Outpatient Duke University Medical Center Durham, NC Emergency Medicine Dermatology Substance Abuse Treatment Migrant Health Cardiology General Surgery Obstetrics-Gynecology Pediatrics |
| positions held |
1984 - 1992 Volunteer lay health worker, Washington (D.C.) Free Clinic (now incorporated into Whitman-Walker Clinic) 1994-present |
|
licensure & certification |
Physician Assistant Licensure:
California License Number PA13514 National Commission on Certification of Physician Assistants Advanced Cardiac Life Support
Subspecialty Credentials: HIV
Medicine |
| professional associations |
American
Academy of HIV Medicine California Academy of HIV Medicine Community Consortium of
Bay Area AIDS Providers American Academy of Physician Assistants Physician Assistant AIDS Network |
| hospital affiliations |
California Pacific Medical Center Castro & Duboce Streets San Francisco, California 94114 |
| honors & awards |
American Medical Student Association Foundation in conjunction with National Health Service Corps Health Promotion-Disease Prevention Project Scholarship, 1994 |
|
Owen WF, Stein C. Efficacy and durability of delavirdine in pharmacokinetic enhancement of protease inhibitors for AIDS patients with extensive antiretroviral therapy (ART) experience. Abstracts of the XIII International AIDS Conference Durban, South Africa, July 9-14, 2000, Abstract WePeB4162 |
|
Owen WF, Stein C. Delavirdine combined with protease inhibitors: durability and efficacy for salvage therapy in AIDS. Program and Abstracts of the 39th Annual Meeting of the Infectious Diseases Society of America San Francisco, California, October 25-28, 2001, Abstract 679 |
| consultant/honoraria |
Gilead Sciences ViiV Healthcare |
| speakers' bureau | ViiV Healthcare |